This Educational course organised by the Heart Failure Association of the ESC was held at the European Heart House on 4-5th May 2007.
The programme took the form of a two day course covering the modern treatment of chronic heart failure - with a world class faculty lecturing on the place of drugs and devices, co-morbidity, and what to do when patients fail to respond to first line therapies. A comparison between the European and North American guidelines highlights the controversial areas of modern practice. The programme included didactic lectures, case strudies and panel discussions.
This educational training programme and related materials are supported by an unrestricted educational grant from Takeda Pharmaceutical Company Limited.
Formats available for download below:
Play webcast
Open pdf slides
Friday 4 May
|
|
Heart failure guidelines in Europe & North America: agreement or disagreement?
Michel Komajda (FR)
|
|
 |
Evidence-based medicine within a budget – where should we spend our money?
Andrew Walker (UK) replaced by Martin Cowie (UK)
|
|
 |
Current controversies in using drugs:
- Accurate diagnosis
- Dosing and sequence
- Polypharmacy
Henry Dargie (UK)
|
|
 |
Current controversies in using electrical devices:
- The European guidelines
- Which patient for which device?
- Using devices for maximum benefit
- What to do at end of patient’s life?
Derek Connelly (UK)
|
|
 |
Joining up the professionals and sectors of care :
- Adequate and timely patient referral through improved communication between relevant specialties
- Education and support of patients and their carers
- Role of nurses in CHF
Theresa McDonagh (UK)
|
|
 |
Joining up the professionals and sectors of care :
- Adequate and timely patient referral through improved communication between relevant specialties
- Education and support of patients and their carers
- Role of nurses in CHF
Bronagh Travers (IRL)
|
|
Saturday 5 May
 |
Tailoring guidelines to the individual patient
Karl Swedberg (Chair, SE)
|
|
|
How well are we implementing evidence-based care?
Michel Komajda (FR)
|
|
|
A case study in implementation: why is the speed so variable?
Martin Cowie (UK)
|
|
|
The Heart Failure Association’s vision
Martin Cowie (UK)
|
|